This work presents a comprehensive contemporary framework for approaching target validation in drug discovery. It begins with a detailed description of new enabling technologies, including aptamers, RNA interference, functional genomics, and proteomics. The next section looks at biologic drug development with in-depth discussion of lessons learned from such well-known cases as Erbitux, Herceptin, and Avastin. Additional targets known as "second generation" drugs, which can be identified when disease pathways are validated by biologics, present new possible small molecule therapeutics and serve as the focus of the final section of the book.
"synopsis" may belong to another edition of this title.
The sequencing of the human genome has offered a genetic description of the entire repertoire of human genes, including a subset of disease targets. Despite this knowledge, now publically available, clinical pipelines are not yet enriched in drugs derived from targets emanating from this massive sequencing effort. A major concern for researchers in the biotechnology and pharmaceutical industries is how to choose the most likely targets for drug discovery and how to validate them.
Target Validation in Drug Discovery describes the background for the choice of target for several successful biological drugs (protein therapeutics). It offers excellent analyses of the underlying biology, the establishment of relative assays, and the translation to clinical trials of these drugs. Professionals in biotechnology and pharmaceutical drug discovery, clinical development, students, and academics in related areas of study will find this a unique reference for years to come.
· Includes detailed descriptions of new enabling technologies, including aptamers, RNA interference, functional genomics, and proteomics
· Takes a look at biologic drug development with in-depth discussion of lessons learned from such well-known cases as Erbitux, Herceptin, and Avastin
· Additional targets known as "second generation" drugs are covered and present new possible small molecule therapeutics
· Details approaches to design of orally active drugs against new disease mechanisms
· Contains contemporary technologies in drug discovery and case histories of successful drugs
"About this title" may belong to another edition of this title.
Shipping:
FREE
Within U.S.A.
Seller: Wonder Book, Frederick, MD, U.S.A.
Condition: Good. Good condition. A copy that has been read but remains intact. May contain markings such as bookplates, stamps, limited notes and highlighting, or a few light stains. Seller Inventory # G08C-00939
Quantity: 1 available
Seller: Basi6 International, Irving, TX, U.S.A.
Condition: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service. Seller Inventory # ABEJUNE24-56796
Quantity: 1 available
Seller: Books Puddle, New York, NY, U.S.A.
Condition: New. pp. 292. Seller Inventory # 26652012
Quantity: 1 available
Seller: Majestic Books, Hounslow, United Kingdom
Condition: New. pp. 292 Illus. Seller Inventory # 8277299
Quantity: 1 available
Seller: Biblios, Frankfurt am main, HESSE, Germany
Condition: New. pp. 292. Seller Inventory # 18652006
Quantity: 1 available
Seller: PBShop.store UK, Fairford, GLOS, United Kingdom
HRD. Condition: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # L1-9780123693938
Quantity: Over 20 available
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Condition: New. In. Seller Inventory # ria9780123693938_new
Quantity: Over 20 available
Seller: THE SAINT BOOKSTORE, Southport, United Kingdom
Hardback. Condition: New. This item is printed on demand. New copy - Usually dispatched within 5-9 working days 851. Seller Inventory # C9780123693938
Quantity: Over 20 available
Seller: Mispah books, Redhill, SURRE, United Kingdom
Hardcover. Condition: Like New. Like New. book. Seller Inventory # ERICA77301236939346
Quantity: 1 available
Seller: moluna, Greven, Germany
Gebunden. Condition: New. Presents a comprehensive framework for approaching target validation in drug discovery. This work begins with a description of enabling technologies, including aptamers, RNA interference, and proteomics. It, then, looks at biologic drug development with dis. Seller Inventory # 594356625
Quantity: Over 20 available